Melola Discovery

← Melola Discovery

Jurnal SINTA 1

The antifungal susceptibility of Candida albicans isolated from HIV/AIDS patients

Dental Journal (Majalah Kedokteran Gigi) · Vol. 54 No. 2 (2021) · hlm. 82–86

DOI
10.20473/j.djmkg.v54.i2.p82-86
ISSN
2442-9740, 1978-3728
Terbit
2021-06-03
Penerbit
Faculty of Dental Medicine, Universitas Airlangga https://fkg.unair.ac.id/en
Bahasa
eng

Abstrak

Background: Candida albicans was found to be dominant in patients with human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS). The antifungals fluconazole, ketoconazole, and nystatin were used as oral candidiasis therapy for HIV/AIDS, each of which has differing susceptibility in oral candidiasis therapy. Purpose: The present study aimed to evaluate the susceptibility and antifungal resistance to oral C. albicans in HIV/AIDS patients. Methods: The subjects followed the universal precaution principles. Oral Candida species were isolated from the saliva of 98 HIV/AIDS subjects. Identification of Candida species was carried out by the mycobiotic agar of API 20 C Aux system. Susceptibility and resistance antifungal tests on the Candida species were performed using a Fungus ATB Kit. Results: Candida albicans was the most dominant species found from 98 subjects (95%). The rest were other Candida species. There are 41 subjects (42%) with a history of oral candidiasis, and 57 subjects (58%) without. The history of those who used antifungals were: nystatin = 60 subjects (61%), fluconazole = 39 subjects (40%), and ketoconazole = two subjects (2%). These antifungals have a susceptibility above 80% against C. albicans, except the nystatin group (79%) (p>0.05; 0.628), but fluconazole has a strong correlation (r=0.820) to susceptibility, susceptibility-dependent dose, and resistance. Conclusion: Candida albicans was dominant in the saliva of HIV/AIDS patients. This fungus was effectively treated by fluconazole, ketoconazole and nystatin. These antifungals had a high susceptibility at ≤ 8 μg/mL to C. albicans.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 111 tautan kepenulisan bersama · 46 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Syiah Kuala
  • University of Indonesia
  • Universitas Sumatera Utara
  • Universitas Trisakti
  • IPB University
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • Universitas Islam Negeri Sultan Syarif Kasim Riau
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Abdillah Imron NasutionUniversitas Syiah Kuala3
Dharli SyafrizaUniversitas Syiah Kuala2
Ayudia RifkiUniversitas Syiah Kuala2
Andi YasmonUniversity of Indonesia2
Ida EffendiUniversitas Trisakti2
Wresti IndriatmiRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Rahmi AmthaUniversitas Trisakti1
Cut SorayaUniversitas Syiah Kuala1
Sunnati SunnatiUniversitas Syiah Kuala1
Nurfal ZikriUniversitas Syiah Kuala1
Rina RahadianurUniversitas Syiah Kuala1
I Wayan Teguh WibawanIPB University1
Boy Muchlis BachtiarUniversity of Indonesia1
Santi ChismirinaUniversitas Syiah Kuala1
Zinatul HayatiUniversitas Syiah Kuala1
Endang Winiati BUniversity of Indonesia1
Nazaruddin NazaruddinUniversitas Islam Negeri Sultan Syarif Kasim Riau1
Lidya SartikaUniversitas Syiah Kuala1
Rahmat Kurniawan AlamUniversitas Syiah Kuala1
Dewi SaputriUniversitas Syiah Kuala1
Mutiara Rizki Wardarni SurbaktiUniversitas Syiah Kuala1
Ridha AndayaniUniversitas Syiah Kuala1
Fitri Yunita BatubaraUniversitas Sumatera Utara1
Ifwandi IfwandiUniversitas Syiah Kuala1
Muhammad Mas'ud HerlambangUniversitas Syiah Kuala1
Shiti Alya FathirahUniversitas Syiah Kuala1
Iceu Estu KurmaenaUniversitas Sumatera Utara1
Cut NurlizaUniversitas Sumatera Utara1
Uswatun HasanahIPB University1
Taufiqi HidayatullahUniversitas Syiah Kuala1
Louisa Ivana UtamiSultan Ageng Tirtayasa University1
Lina HerliyanaAfiliasi tidak diketahui1
Grady KrisandiUniversity of Indonesia1
Erike A. SuwarsonoSyarif Hidayatullah State Islamic University Jakarta1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://e-journal.unair.ac.id/MKG/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The antifungal susceptibility of Candida albicans isolated from HIV/AIDS patients</dc:title>
	<dc:creator>Rezeki, Sri</dc:creator>
	<dc:creator>Pradono, Siti Aliyah</dc:creator>
	<dc:creator>Subita, Gus Permana</dc:creator>
	<dc:creator>Rosana, Yeva</dc:creator>
	<dc:creator>Sunnati, S.</dc:creator>
	<dc:creator>Gani, Basri A.</dc:creator>
	<dc:subject xml:lang="en-US">antifungal</dc:subject>
	<dc:subject xml:lang="en-US">Candida albicans</dc:subject>
	<dc:subject xml:lang="en-US">HIV/AIDS</dc:subject>
	<dc:subject xml:lang="en-US">susceptibility and resistance</dc:subject>
	<dc:description xml:lang="en-US">Background: Candida albicans was found to be dominant in patients with human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS). The antifungals fluconazole, ketoconazole, and nystatin were used as oral candidiasis therapy for HIV/AIDS, each of which has differing susceptibility in oral candidiasis therapy. Purpose: The present study aimed to evaluate the susceptibility and antifungal resistance to oral C. albicans in HIV/AIDS patients. Methods: The subjects followed the universal precaution principles. Oral Candida species were isolated from the saliva of 98 HIV/AIDS subjects. Identification of Candida species was carried out by the mycobiotic agar of API 20 C Aux system. Susceptibility and resistance antifungal tests on the Candida species were performed using a Fungus ATB Kit. Results: Candida albicans was the most dominant species found from 98 subjects (95%). The rest were other Candida species. There are 41 subjects (42%) with a history of oral candidiasis, and 57 subjects (58%) without. The history of those who used antifungals were: nystatin = 60 subjects (61%), fluconazole = 39 subjects (40%), and ketoconazole = two subjects (2%). These antifungals have a susceptibility above 80% against C. albicans, except the nystatin group (79%) (p&amp;gt;0.05; 0.628), but fluconazole has a strong correlation (r=0.820) to susceptibility, susceptibility-dependent dose, and resistance. Conclusion: Candida albicans was dominant in the saliva of HIV/AIDS patients. This fungus was effectively treated by fluconazole, ketoconazole and nystatin. These antifungals had a high susceptibility at ≤ 8 μg/mL to C. albicans. </dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Dental Medicine, Universitas Airlangga https://fkg.unair.ac.id/en</dc:publisher>
	<dc:date>2021-06-03</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://e-journal.unair.ac.id/MKG/article/view/25034</dc:identifier>
	<dc:identifier>10.20473/j.djmkg.v54.i2.p82-86</dc:identifier>
	<dc:source xml:lang="en-US">Dental Journal (Majalah Kedokteran Gigi); Vol. 54 No. 2 (2021): June 2021; 82-86</dc:source>
	<dc:source>2442-9740</dc:source>
	<dc:source>1978-3728</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://e-journal.unair.ac.id/MKG/article/view/25034/14371</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Dental Journal (Majalah Kedokteran Gigi)</dc:rights>
</oai_dc:dc>